Champions Oncology (CSBR) Other financing activities (2011 - 2026)
Champions Oncology's (CSBR) quarterly Other financing activities came in at $52000.0 in Q3 2026, up 116.67% year-over-year from $24000.0 in Q3 2025, and up 1633.33% on a QoQ basis from $3000.0 in Q1 2026.
Powered by 
Analysis
Champions Oncology (CSBR) Other financing activities (2011 - 2026) Analysis & Trends
Champions Oncology (CSBR) has 12 years of Other financing activities data on file, last reported at $52000.0 in Q3 2026.
- On a quarterly basis, Other financing activities rose 116.67% year-over-year to $52000.0 in Q3 2026; TTM through Jul 2026 was $262000.0, a 23.84% decrease from a year earlier, with the FY2026 full-year figure at $234000.0, down 26.88% from the prior year.
- Other financing activities for Q3 2026 stood at $52000.0, up from $3000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $276000.0 in Q4 2024 and bottomed at -$1000.0 in Q2 2023.
- Historically, Other financing activities has averaged $78000.0 across 4 years, with a median of $24000.0 in 2025.
- The widest annual swing landed in 2025, when Other financing activities jumped 500.0%; it then plunged 92.11% in 2026.
- Year by year, Other financing activities stood at $240000.0 in 2023, then advanced by 15.0% to $276000.0 in 2024, then declined by 25.0% to $207000.0 in 2025, then slumped by 74.88% to $52000.0 in 2026.
- Per Business Quant data, the three most recent Other financing activities figures were $52000.0 in Q3 2026, $3000.0 in Q1 2026, and $207000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 52,000.00 |
| Jan 31, 2026 | 3,000.00 |
| Oct 31, 2025 | 207,000.00 |
| Jul 31, 2025 | 24,000.00 |
| Apr 30, 2025 | 6,000.00 |
| Jan 31, 2025 | 38,000.00 |
| Oct 31, 2024 | 276,000.00 |
| Apr 30, 2024 | 1,000.00 |
| Oct 31, 2023 | 240,000.00 |
| Jul 31, 2023 | 12,000.00 |
| Apr 30, 2023 | -1,000.00 |
| Jan 31, 2020 | 427,000.00 |
| Oct 31, 2019 | 2,000.00 |
| Jan 31, 2019 | 364,000.00 |
| Oct 31, 2018 | 1.03 Mn |
| Jul 31, 2018 | 42,000.00 |
| Jan 31, 2018 | 38,000.00 |
| Jul 31, 2015 | -18,000.00 |
| Apr 30, 2015 | 11.22 Mn |
| Jan 31, 2014 | -9,000.00 |